SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 240 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $834,736 | +52366.1% | 27,769 | -36.8% | 0.01% | -60.0% |
| Q1 2023 | $1,591 | -44.7% | 43,906 | -45.6% | 0.02% | -56.1% |
| Q4 2022 | $2,879 | -99.9% | 80,707 | -12.0% | 0.06% | -14.9% |
| Q3 2022 | $3,106,000 | -3.4% | 91,757 | -17.5% | 0.07% | -20.2% |
| Q2 2022 | $3,215,000 | -22.3% | 111,183 | -13.2% | 0.08% | -13.4% |
| Q1 2022 | $4,139,000 | +64.8% | 128,077 | +48.7% | 0.10% | +131.0% |
| Q4 2021 | $2,511,000 | +37.3% | 86,113 | +25.5% | 0.04% | +40.0% |
| Q3 2021 | $1,829,000 | +449.2% | 68,597 | +535.2% | 0.03% | +400.0% |
| Q2 2021 | $333,000 | -71.8% | 10,800 | -76.1% | 0.01% | -75.0% |
| Q1 2021 | $1,181,000 | +121.6% | 45,129 | +52.4% | 0.02% | -50.0% |
| Q1 2020 | $533,000 | -48.1% | 29,620 | -31.5% | 0.05% | +4.3% |
| Q4 2019 | $1,026,000 | +5.8% | 43,247 | +22.5% | 0.05% | +39.4% |
| Q3 2019 | $970,000 | -36.6% | 35,295 | -23.7% | 0.03% | -25.0% |
| Q2 2019 | $1,531,000 | +5.4% | 46,265 | +11.5% | 0.04% | -26.7% |
| Q1 2019 | $1,453,000 | +22.4% | 41,481 | +16.1% | 0.06% | +160.9% |
| Q4 2018 | $1,187,000 | +259.7% | 35,717 | +238.6% | 0.02% | +130.0% |
| Q1 2017 | $330,000 | -52.6% | 10,548 | -61.8% | 0.01% | -44.4% |
| Q4 2016 | $696,000 | +90.2% | 27,577 | +86.3% | 0.02% | +100.0% |
| Q3 2016 | $366,000 | +24.1% | 14,800 | +2.1% | 0.01% | +50.0% |
| Q2 2016 | $295,000 | -4.8% | 14,500 | -28.6% | 0.01% | -25.0% |
| Q1 2016 | $310,000 | -50.9% | 20,300 | -56.8% | 0.01% | -55.6% |
| Q4 2015 | $632,000 | +34.2% | 47,000 | +39.9% | 0.02% | +12.5% |
| Q3 2015 | $471,000 | +11.3% | 33,600 | +34.9% | 0.02% | +33.3% |
| Q2 2015 | $423,000 | -18.7% | 24,900 | -42.1% | 0.01% | -29.4% |
| Q1 2015 | $520,000 | +348.3% | 42,987 | +207.8% | 0.02% | +325.0% |
| Q4 2014 | $116,000 | – | 13,966 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |